No acute antimigraine efficacy of CP‐122,288, a highly potent inhibitor of neurogenic inflammation: Results of two randomized, double‐blind, placebo‐controlled clinical trials
暂无分享,去创建一个
J. Olesen | K. Roon | D. Kleinermans | P. Ellis | J. Hettiarachchi | H. Diener | P. Poole | M. Ferrari | M. Ferrari | K. I. Roon | I. Christianssen | J. G. Kok | J. G. Kok